Report Detail
Global Pulmonary Drugs Market Professional Survey Report 2019
- RnM3809586 |
- 09 October, 2019 |
- Global |
- 102 Pages |
- QYResearch |
- Pharma & Healthcare
The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the common cold to cure long-term disorders such asthma. These agents are available in different forms such as oral tablets, oral liquids, and injections or inhalations. Inhalations deliver the medicine directly to the lungs, which can act directly on the lung tissues, minimizing systemic side effects.
The major factors driving growth of the pulmonary drugs market include increasing incidence of chronic respiratory diseases, tobacco smoking, and government and non-government initiatives.
The global Pulmonary Drugs market was valued at 30400 million US$ in 2018 and will reach 56600 million US$ by the end of 2025, growing at a CAGR of 8.1% during 2019-2025.
This report focuses on Pulmonary Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pulmonary Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pulmonary Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pulmonary Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Sanofi SA
Meda Pharmaceuticals
Circassia Pharmaceuticals Plc.
AstraZeneca Plc.
GlaxoSmithKline Plc.
Mallinckrodt Pharmaceuticals Plc.
Cheisi Farmaceutici S.p.A
Zambon Company S.p.A
Alaxia SAS
Merck Sharp & Dohme Limited
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Inhaled Corticosteroids
Long Acting Beta-2 Agonists
Antihistamines
Vasodilators
Others
Segment by Application
Asthma & COPD
Allergic Rhinitis
Pulmonary Arterial Hypertension
Cystic Fibrosis
Others
Table of Contents
Executive Summary
1 Industry Overview of Pulmonary Drugs
- 1.1 Definition of Pulmonary Drugs
- 1.2 Pulmonary Drugs Segment by Type
- 1.2.1 Global Pulmonary Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Inhaled Corticosteroids
- 1.2.3 Long Acting Beta-2 Agonists
- 1.2.4 Antihistamines
- 1.2.5 Vasodilators
- 1.2.6 Others
- 1.3 Pulmonary Drugs Segment by Applications
- 1.3.1 Global Pulmonary Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Asthma & COPD
- 1.3.3 Allergic Rhinitis
- 1.3.4 Pulmonary Arterial Hypertension
- 1.3.5 Cystic Fibrosis
- 1.3.6 Others
- 1.4 Global Pulmonary Drugs Overall Market
- 1.4.1 Global Pulmonary Drugs Revenue (2014-2025)
- 1.4.2 Global Pulmonary Drugs Production (2014-2025)
- 1.4.3 North America Pulmonary Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Pulmonary Drugs Status and Prospect (2014-2025)
- 1.4.5 China Pulmonary Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Pulmonary Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Pulmonary Drugs Status and Prospect (2014-2025)
- 1.4.8 India Pulmonary Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Pulmonary Drugs
- 2.3 Manufacturing Process Analysis of Pulmonary Drugs
- 2.4 Industry Chain Structure of Pulmonary Drugs
3 Development and Manufacturing Plants Analysis of Pulmonary Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Pulmonary Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Pulmonary Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Pulmonary Drugs Production and Capacity Analysis
- 4.2 Pulmonary Drugs Revenue Analysis
- 4.3 Pulmonary Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Pulmonary Drugs Regional Market Analysis
- 5.1 Pulmonary Drugs Production by Regions
- 5.1.1 Global Pulmonary Drugs Production by Regions
- 5.1.2 Global Pulmonary Drugs Revenue by Regions
- 5.2 Pulmonary Drugs Consumption by Regions
- 5.3 North America Pulmonary Drugs Market Analysis
- 5.3.1 North America Pulmonary Drugs Production
- 5.3.2 North America Pulmonary Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Pulmonary Drugs Import and Export
- 5.4 Europe Pulmonary Drugs Market Analysis
- 5.4.1 Europe Pulmonary Drugs Production
- 5.4.2 Europe Pulmonary Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Pulmonary Drugs Import and Export
- 5.5 China Pulmonary Drugs Market Analysis
- 5.5.1 China Pulmonary Drugs Production
- 5.5.2 China Pulmonary Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Pulmonary Drugs Import and Export
- 5.6 Japan Pulmonary Drugs Market Analysis
- 5.6.1 Japan Pulmonary Drugs Production
- 5.6.2 Japan Pulmonary Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Pulmonary Drugs Import and Export
- 5.7 Southeast Asia Pulmonary Drugs Market Analysis
- 5.7.1 Southeast Asia Pulmonary Drugs Production
- 5.7.2 Southeast Asia Pulmonary Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Pulmonary Drugs Import and Export
- 5.8 India Pulmonary Drugs Market Analysis
- 5.8.1 India Pulmonary Drugs Production
- 5.8.2 India Pulmonary Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Pulmonary Drugs Import and Export
6 Pulmonary Drugs Segment Market Analysis (by Type)
- 6.1 Global Pulmonary Drugs Production by Type
- 6.2 Global Pulmonary Drugs Revenue by Type
- 6.3 Pulmonary Drugs Price by Type
7 Pulmonary Drugs Segment Market Analysis (by Application)
- 7.1 Global Pulmonary Drugs Consumption by Application
- 7.2 Global Pulmonary Drugs Consumption Market Share by Application (2014-2019)
8 Pulmonary Drugs Major Manufacturers Analysis
- 8.1 Sanofi SA
- 8.1.1 Sanofi SA Pulmonary Drugs Production Sites and Area Served
- 8.1.2 Sanofi SA Product Introduction, Application and Specification
- 8.1.3 Sanofi SA Pulmonary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Meda Pharmaceuticals
- 8.2.1 Meda Pharmaceuticals Pulmonary Drugs Production Sites and Area Served
- 8.2.2 Meda Pharmaceuticals Product Introduction, Application and Specification
- 8.2.3 Meda Pharmaceuticals Pulmonary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Circassia Pharmaceuticals Plc.
- 8.3.1 Circassia Pharmaceuticals Plc. Pulmonary Drugs Production Sites and Area Served
- 8.3.2 Circassia Pharmaceuticals Plc. Product Introduction, Application and Specification
- 8.3.3 Circassia Pharmaceuticals Plc. Pulmonary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 AstraZeneca Plc.
- 8.4.1 AstraZeneca Plc. Pulmonary Drugs Production Sites and Area Served
- 8.4.2 AstraZeneca Plc. Product Introduction, Application and Specification
- 8.4.3 AstraZeneca Plc. Pulmonary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 GlaxoSmithKline Plc.
- 8.5.1 GlaxoSmithKline Plc. Pulmonary Drugs Production Sites and Area Served
- 8.5.2 GlaxoSmithKline Plc. Product Introduction, Application and Specification
- 8.5.3 GlaxoSmithKline Plc. Pulmonary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Mallinckrodt Pharmaceuticals Plc.
- 8.6.1 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Production Sites and Area Served
- 8.6.2 Mallinckrodt Pharmaceuticals Plc. Product Introduction, Application and Specification
- 8.6.3 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Cheisi Farmaceutici S.p.A
- 8.7.1 Cheisi Farmaceutici S.p.A Pulmonary Drugs Production Sites and Area Served
- 8.7.2 Cheisi Farmaceutici S.p.A Product Introduction, Application and Specification
- 8.7.3 Cheisi Farmaceutici S.p.A Pulmonary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Zambon Company S.p.A
- 8.8.1 Zambon Company S.p.A Pulmonary Drugs Production Sites and Area Served
- 8.8.2 Zambon Company S.p.A Product Introduction, Application and Specification
- 8.8.3 Zambon Company S.p.A Pulmonary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Alaxia SAS
- 8.9.1 Alaxia SAS Pulmonary Drugs Production Sites and Area Served
- 8.9.2 Alaxia SAS Product Introduction, Application and Specification
- 8.9.3 Alaxia SAS Pulmonary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Merck Sharp & Dohme Limited
- 8.10.1 Merck Sharp & Dohme Limited Pulmonary Drugs Production Sites and Area Served
- 8.10.2 Merck Sharp & Dohme Limited Product Introduction, Application and Specification
- 8.10.3 Merck Sharp & Dohme Limited Pulmonary Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Pulmonary Drugs Market
- 9.1 Global Pulmonary Drugs Market Trend Analysis
- 9.1.1 Global Pulmonary Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Pulmonary Drugs Regional Market Trend
- 9.2.1 North America Pulmonary Drugs Forecast 2019-2025
- 9.2.2 Europe Pulmonary Drugs Forecast 2019-2025
- 9.2.3 China Pulmonary Drugs Forecast 2019-2025
- 9.2.4 Japan Pulmonary Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Pulmonary Drugs Forecast 2019-2025
- 9.2.6 India Pulmonary Drugs Forecast 2019-2025
- 9.3 Pulmonary Drugs Market Trend (Product Type)
- 9.4 Pulmonary Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Pulmonary Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Pulmonary Drugs. Industry analysis & Market Report on Pulmonary Drugs is a syndicated market report, published as Global Pulmonary Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Pulmonary Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
